Related Experiment Video
Updated: Jun 20, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease
Tadeusz Przewłocki1, Anna Kabłak-Ziembicka, Artur Kozanecki
1Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Collegium Medicum, The John Paul II Hospital, Krakow, Poland. tadeuszprzewlocki@op.pl
Insights
Significant atherosclerosis affects 36% of patients with coronary artery disease (CAD). Factors like smoking, high creatinine, and female gender predict polyvascular atherosclerosis (PVA) in these patients.
Area of Science:
- Cardiovascular Medicine
- Atherosclerosis Research
- Vascular Disease Epidemiology
Background:
- Cardiovascular diseases are a leading cause of death globally, with increasing prevalence of coronary artery disease (CAD), peripheral arterial disease (PAD), supra-aortic arterial disease (SAD), and renal stenosis (RAS).
- Polyvascular atherosclerosis (PVA), affecting multiple arterial territories, significantly worsens cardiovascular outcomes.
Purpose of the Study:
- To investigate the prevalence, coexistence, and predictors of significant PAD, SAD, and RAS in individuals suspected of having CAD.
- To understand the extent of atherosclerosis beyond the coronary arteries in a patient cohort undergoing coronary angiography.
Main Methods:
- Analysis of angiography data from 687 consecutive patients (mean age 63.5 years) undergoing coronary angiography.
- Stenosis of >=50% in CAD, SAD, PAD, and RAS was quantified.
- Logistic regression analysis identified independent predictors of multi-territory PVA.
Main Results:
- Significant CAD was detected in 79.3% of patients.
- Extracoronary atherosclerosis was prevalent: SAD in 19.8%, RAS in 8%, and PAD in 15%.
- Independent predictors for at least 2-territory PVA included multivessel CAD, hyperlipidemia, smoking, elevated creatinine, lower extremity claudication, and female gender.
Conclusions:
- A substantial proportion (36%) of patients with documented CAD also exhibit significant atherosclerosis in extracoronary arteries.
- The presence and severity of PVA correlate with an increased burden of atherosclerosis risk factors and a history of atherothrombotic events.
Background:
Cardiovascular diseases are the number one killer in the developed countries, accounting for approximately half of all deaths, with the leading causes being myocardial infarction and ischaemic stroke. In line with the ageing population, the prevalence of coronary artery disease (CAD), lower extremity peripheral arterial disease (PAD), supra-aortic arterial disease (SAD) and renal stenosis (RAS) is increasing. Polyvascular atherosclerosis (PVA) coexisting in several territories has an adverse effect on cardiovascular morbidity and mortality.
Aim:
To determine prevalence, coexistence and predictors of significant PAD, SAD and RAS in patients with suspected CAD.
Methods:
Based on angiography, the frequency of coexisting CAD, SAD, PAD and RAS (stenosis > or =50%) was determined in 687 (487 male) consecutive patients, aged 63.5 +/- 9.1 years, referred for coronary angiography.
Results:
Significant CAD was found in 545 (79.3%) patients (1-vessel in 164; 2-vessel in 157; 3-vessel in 224). SAD, RAS and PAD were found in 136 (19.8%), 55 (8%), and 103 (15%) patients, respectively. Of the 545 patients with confirmed CAD, 346 (63.5%) had stenoses limited to coronary arteries. 2-, 3- and 4-level PVA was found in 130 (23.8%), 61 (11.2%) and 8 (1.5%) patients, respectively. Of the 142 patients without CAD, 127 (89.4%) had no significant stenoses elsewhere, 12 (8.5%) had 1 extracoronary territory and 3 (2.1%) had 2-territory involvement. Backward stepwise binary logistic regression analysis showed the following independent predictors of at least 2-level PVA: 2- and 3-vessel CAD (p < 0.001), hyperlipidaemia (p = 0.067), smoking (p < 0.001), creatinine level > or = 1.3 ml/dl (p < 0.001), lower extremities claudication (p < 0.001) and female gender (p = 0.003). The relative risk of having at least 2-territory PVA was 15.7-fold higher in patients with claudication, 2.1-fold in patients with multivessel CAD, 2.8-fold for serum creatinine level > 1.3 mg/dl; and 1.9-fold, 2.4-fold and 2-fold in patients with hyperlipidaemia, smokers and women, respectively.
Conclusions:
Significant atherosclerosis in extracoronary arterial territories is present in 36% of patients with documented CAD. With advancing PVA, accumulation of atherosclerosis risk factors, previous atherothrombotic events and more severe CAD is observed.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
